Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Parasitic Diseases

  Free Subscription


Articles published in Trop Med Int Health

Retrieve available abstracts of 33 articles:
HTML format
Text format



Single Articles


    July 2019
  1. DE CARVALHO IPSF, Maia Peixoto H, Adolfo Sierra Romero G, de Oliveira MRF, et al
    Treatment for human visceral leishmaniasis: a cost-effectiveness analysis for Brazil.
    Trop Med Int Health. 2019 Jul 6. doi: 10.1111/tmi.13284.
    PubMed     Text format     Abstract available


    May 2019
  2. IGBASI U, Oyibo W, Omilabu S, Quan H, et al
    Kelch 13 propeller gene polymorphism among Plasmodium falciparum isolates in Lagos, Nigeria: Molecular Epidemiologic Study.
    Trop Med Int Health. 2019 May 27. doi: 10.1111/tmi.13273.
    PubMed     Text format     Abstract available


    March 2019
  3. MOUAHID G, Nguema RM, Al Mashikhi KM, Al Yafae SA, et al
    Host-parasite life-histories of the diurnal versus nocturnal chronotypes of Schistosoma mansoni: adaptive significance.
    Trop Med Int Health. 2019 Mar 9. doi: 10.1111/tmi.13227.
    PubMed     Text format     Abstract available


  4. PEPRAH S, Dhudha H, Ally H, Masalu N, et al
    A population-based study of the prevalence and risk-factors of low-grade Plasmodium falciparum malaria infection in children aged 0-15 years old in northern Tanzania.
    Trop Med Int Health. 2019 Mar 7. doi: 10.1111/tmi.13225.
    PubMed     Text format     Abstract available


    February 2019
  5. NDERU D, Kimani F, Karanja E, Thiong'o K, et al
    Genetic diversity and population structure of P. falciparum in Kenyan-Ugandan border areas.
    Trop Med Int Health. 2019 Feb 28. doi: 10.1111/tmi.13223.
    PubMed     Text format     Abstract available


  6. SANTOS BM, Soares FA, Rosa SL, da Conceicao Ferreira Gomes D, et al
    TF-Test Quantified: A New Technique for Diagnosis of Schistosoma mansoni Eggs.
    Trop Med Int Health. 2019 Feb 10. doi: 10.1111/tmi.13215.
    PubMed     Text format     Abstract available


    January 2019
  7. CARVALHO SH, Frezard F, Pereira NP, Moura AS, et al
    American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment.
    Trop Med Int Health. 2019 Jan 25. doi: 10.1111/tmi.13210.
    PubMed     Text format     Abstract available


    December 2018
  8. DE ALMEIDA RODRIGUES MG, de Brito Sousa JD, Dias ALB, Monteiro WM, et al
    The role of deforestation on American Cutaneous Leishmaniasis incidence: spatial-temporal distribution, environmental and socioeconomic factors associated in the Brazilian Amazon.
    Trop Med Int Health. 2018 Dec 21. doi: 10.1111/tmi.13196.
    PubMed     Text format     Abstract available


  9. LIM D, Banjara MR, Singh VK, Joshi AB, et al
    Barriers of Visceral Leishmaniasis reporting and surveillance in Nepal: comparison of governmental VL-program districts with non-program districts.
    Trop Med Int Health. 2018 Dec 18. doi: 10.1111/tmi.13189.
    PubMed     Text format     Abstract available


  10. DIAB RG, Mady RF, Tolba MM, Ghazala RAM, et al
    Urinary circulating DNA and circulating antigen for diagnosis of schistosomiasis mansoni: a field study.
    Trop Med Int Health. 2018 Dec 14. doi: 10.1111/tmi.13193.
    PubMed     Text format     Abstract available


    October 2018
  11. KOSTYGOV AY, Butenko A, Yurchenko V, Motazedian MH, et al
    On monoxenous trypanosomatids from lesions of immunocompetent patients with suspected cutaneous leishmaniasis in Iran.
    Trop Med Int Health. 2018 Oct 11. doi: 10.1111/tmi.13168.
    PubMed     Text format     Abstract available


    July 2018
  12. DE AGUIAR MG, Goncalves JE, Souza MD, de Silva RE, et al
    Plasma antimony determination during cutaneous leishmaniasis treatment with intralesional infiltration of meglumine antimoniate.
    Trop Med Int Health. 2018 Jul 27. doi: 10.1111/tmi.13130.
    PubMed     Text format     Abstract available


  13. MENESES GC, De Francesco Daher E, da Silva Junior GB, Bezerra GF, et al
    Visceral leishmaniasis-associated nephropathy in hospitalized Brazilian patients: new insights based on kidney injury biomarkers.
    Trop Med Int Health. 2018 Jul 10. doi: 10.1111/tmi.13127.
    PubMed     Text format     Abstract available


    June 2018
  14. MISCHLINGER J, Pitzinger P, Veletzky L, Groger M, et al
    Validity and reliability of methods to microscopically detect and quantify malaria parasitaemia.
    Trop Med Int Health. 2018 Jun 28. doi: 10.1111/tmi.13124.
    PubMed     Text format     Abstract available


  15. NGOUATEU AT, Kirstein OD, Ngouateu OB, Kruger A, et al
    First detection of Leishmania donovani in sand flies from Cameroon and its epidemiological implications.
    Trop Med Int Health. 2018 Jun 27. doi: 10.1111/tmi.13123.
    PubMed     Text format     Abstract available


  16. MACHADO PRL, Ribeiro CS, Franca-Costa J, Dourado MEF, et al
    Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomized trial.
    Trop Med Int Health. 2018 Jun 20. doi: 10.1111/tmi.13119.
    PubMed     Text format     Abstract available


  17. GANDASEGUI J, Fernandez-Soto P, Dacal E, Rodriguez E, et al
    Field and laboratory comparative evaluation of a LAMP assay for the diagnosis of urogenital schistosomiasis in Cubal, Central Angola.
    Trop Med Int Health. 2018 Jun 19. doi: 10.1111/tmi.13117.
    PubMed     Text format     Abstract available


    May 2018
  18. TOHIDINIK HR, Mohebali M, Mansournia MA, Niakan Kalhori SR, et al
    Forecasting zoonotic cutaneous leishmaniasis using meteorological factors in eastern Fars province, Iran: A SARIMA Analysis.
    Trop Med Int Health. 2018 May 22. doi: 10.1111/tmi.13079.
    PubMed     Text format     Abstract available


    April 2018
  19. OLIAEE RT, Sharifi I, Afgar A, Kareshk AT, et al
    Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.
    Trop Med Int Health. 2018 Apr 30. doi: 10.1111/tmi.13062.
    PubMed     Text format     Abstract available


    March 2018
  20. LOPEZ L, Velez I, Arbelaez MP, Olliaro P, et al
    Eligibility criteria and outcome measures adopted in clinical trials of treatments of cutaneous leishmaniasis: systematic literature review covering the period 1991-2015.
    Trop Med Int Health. 2018 Mar 9. doi: 10.1111/tmi.13048.
    PubMed     Text format     Abstract available


    February 2018
  21. GHOBAKHLOO N, Motazedian MH, Naderi S, Sepideh E, et al
    Isolation of Crithidia spp. from lesions of immunocompetent patients with suspected cutaneous leishmaniasis in Iran.
    Trop Med Int Health. 2018 Feb 15. doi: 10.1111/tmi.13042.
    PubMed     Text format     Abstract available


    December 2017
  22. GARCIA CB, Pintar Z, Serres X, Mendioroz J, et al
    Ultrasound findings and associated factors to morbidity in Schistosoma haematobium infection in a highly endemic setting.
    Trop Med Int Health. 2017 Dec 4. doi: 10.1111/tmi.13020.
    PubMed     Text format     Abstract available


    November 2017
  23. ADEDOJA A, Hoan NX, van Tong H, Adukpo S, et al
    Differential contribution of interleukin-10 promoter variants in malaria and schistosomiasis mono- and co-infections among Nigerian children.
    Trop Med Int Health. 2017 Nov 13. doi: 10.1111/tmi.13007.
    PubMed     Text format     Abstract available


  24. KANAMITIE JN, Ahorlu CS, Otchere J, Aboagye-Antwi F, et al
    Twelve-month longitudinal parasitological assessment of lymphatic filariasis-positive individuals: impact of a biannual treatment with ivermectin and albendazole.
    Trop Med Int Health. 2017;22:1451-1456.
    PubMed     Text format     Abstract available


    October 2017
  25. MISTRO S, Gomes B, Rosa L, Miranda L, et al
    Cost-effectiveness of liposomal amphotericin B in hospitalized patients with mucocutaneous leishmaniasis.
    Trop Med Int Health. 2017 Oct 27. doi: 10.1111/tmi.12996.
    PubMed     Text format     Abstract available


  26. DE CARVALHO IPSF, Peixoto HM, Romero GAS, de Oliveira MRF, et al
    Cost of visceral leishmaniasis care in Brazil.
    Trop Med Int Health. 2017 Oct 27. doi: 10.1111/tmi.12994.
    PubMed     Text format     Abstract available


  27. KAUR H, Sehgal R, Goyal K, Makkar N, et al
    Genetic diversity of Plasmodium falciparum merozoite surface protein-1 (block 2), glutamate rich protein and sexual stage antigen Pfs25 from Chandigarh, North India.
    Trop Med Int Health. 2017 Oct 13. doi: 10.1111/tmi.12990.
    PubMed     Text format     Abstract available


  28. TSAKMAKIDIS IOTA, Angelopoulou K, Dovas CI, Dokianakis Epsilon, et al
    Leishmania infection in rodents in Greece.
    Trop Med Int Health. 2017 Oct 6. doi: 10.1111/tmi.12982.
    PubMed     Text format     Abstract available


    August 2017
  29. INOCENCIO DA LUZ R, Linsuke S, Lutumba P, Hasker E, et al
    Assessment of Schistosomiasis and Soil-Transmitted Helminths prevalence in school-aged children and opportunities for integration of control in local health services in Kwilu province, the Democratic Republic of the Congo.
    Trop Med Int Health. 2017 Aug 29. doi: 10.1111/tmi.12965.
    PubMed     Text format     Abstract available


    July 2017
  30. FIKRE H, Mohammed R, Atinafu S, van Griensven J, et al
    Clinical features and treatment response of cutaneous leishmaniasis in North-West Ethiopia.
    Trop Med Int Health. 2017 Jul 16. doi: 10.1111/tmi.12928.
    PubMed     Text format     Abstract available


    June 2017
  31. ZAIDI F, Fatima SH, Jan T, Fatima M, et al
    Environmental risk modeling and potential sand-fly vectors of Cutaneous Leishmaniasis in Chitral District: A leishmanial focal point of mount Tirchmir, Pakistan.
    Trop Med Int Health. 2017 Jun 27. doi: 10.1111/tmi.12916.
    PubMed     Text format     Abstract available


  32. KANSAL S, Chakravarty J, Kumar A, Malaviya P, et al
    Risk Factors associated with defaulting from visceral leishmaniasis treatment: analysis under routine program conditions in Bihar, India.
    Trop Med Int Health. 2017 Jun 8. doi: 10.1111/tmi.12906.
    PubMed     Text format     Abstract available


    April 2017
  33. ZACARIAS DA, Rolao N, de Pinho FA, Sene I, et al
    Causes and consequences of the Leishmania infantum burden in patients with kala-azar -NDASH- a study of 625 patients.
    Trop Med Int Health. 2017 Apr 5. doi: 10.1111/tmi.12877.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parasitic Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: